Richard Lifton, 62, is an internationally recognized physician-scientist working at the cutting edge of genomics, and an academic leader who is deeply committed to bridging basic science with medical innovation. He will take office on September 1.
Timothy O’Connor’s promotion is expected to further integrate the university’s executive administrative functions, and facilitate the transition to the next president.
Gabriel Victora, who will join Rockefeller in September of next year, investigates how the immune system generates high affinity antibodies.
Alipasha Vaziri, who was appointed a tenure-track professor in September, devises tools for creating dynamic maps of neural activity within living brains.
Meet Collette Ryder, the new director of Office of Sponsored Research and Program Development, who brings many years of experience in sponsored projects administration and compliance.
When Susan King first began her career in scientific publishing, with a Ph.D. in immunology from the University of Glasgow and after a three-year postdoc at St George’s Hospital Medical School (now St George’s, University of London), she wasn’t sure what to expect of life outside the lab.
Andrea Morris’s career in biology has had a few curves. After earning a Ph.D. in molecular biology and doing a postdoc, she took a tenure-track faculty job, teaching and running a lab at a small liberal arts college. But she ultimately gave up tenure, and the bench, to work in higher education administration. Now, as the newly hired director of career resources and professional development in Rockefeller’s Dean’s Office, she is charting yet another course, putting her biology Ph.D. to work in ways Rockefeller students and postdocs can appreciate.
An endless stream of compelling discoveries emerges regularly from Rockefeller’s research community and it is the job of the Office of Communications and Public Affairs to make sure those findings are accessible internally and externally. The new executive director of the office, Franklin Hoke, brings with him a background as a veteran science journalist and communications leader in academic settings, and he plans to bolster the office’s core mission to disseminate scientific news. He joined the university in June.
When Timothy P. O’Connor left his faculty position in the department of genetic medicine at Weill Cornell Medical College in 2009, it was for an opportunity he couldn’t pass up — to be associate provost for science and technology at Yale University. He would be a key part of the leadership team in charge of tackling tough questions about how best to allocate resources to support scientists. But it also meant leaving the city he had come to love as his adopted hometown. After four years in New Haven, however, he has made his way back to New York, landing just a block away from the institution he called home for seven years. The role he has accepted at Rockefeller is not unlike the one he had at Yale, but Rockefeller’s lean administration and exclusive scientific focus, along with its ambitious new strategic plan, means he will have the opportunity to focus on both the big picture issues and day-to-day operations involved in running the institution. Dr. O’Connor was named vice president for university strategy and research operations, as well as chief of staff in the president’s office, in April. He started in June.
The Rockefeller University has appointed Amy C. Falls as chief investment officer and vice president for investments. She succeeds Lisa Danzig, who is leaving Rockefeller after 10 years to pursue new challenges. Ms. Falls begins on April 4, and Ms. Danzig will remain until then to assist with the transition.